Display options
Share it on

Clin Transl Gastroenterol. 2017 Apr 06;8(4):e83. doi: 10.1038/ctg.2017.12.

Endoscopy-Guided Evaluation of Duodenal Mucosal Permeability in Functional Dyspepsia.

Clinical and translational gastroenterology

Hideaki Ishigami, Tomoaki Matsumura, Shingo Kasamatsu, Shinsaku Hamanaka, Takashi Taida, Kenichiro Okimoto, Keiko Saito, Shoko Minemura, Daisuke Maruoka, Tomoo Nakagawa, Tatsuro Katsuno, Mai Fujie, Makoto Arai

Affiliations

  1. Department of Gastroenterology and Nephrology, Graduate School of Medicine, Chiba University, Chiba-City, Japan.
  2. Clinical Engineering Center, Chiba University Hospital, Chiba-City, Japan.

PMID: 28383567 PMCID: PMC5415894 DOI: 10.1038/ctg.2017.12

Abstract

OBJECTIVES: The pathophysiology of functional dyspepsia (FD) is not fully understood. Impaired duodenal mucosal integrity characterized by increased mucosal permeability and/or low-grade inflammation was reported as potentially important etiologies. We aimed to determine the utility of a recently developed simple catheterization method to measure mucosal admittance (MA), the inverse of mucosal impedance, for evaluation of duodenal mucosal permeability in patients with FD.

METHODS: We conducted two prospective studies. In the first study, duodenal MA of 23 subjects was determined by catheterization during upper endoscopy, and transepithelial electrical resistance (TEER) of duodenal biopsy samples in Ussing chambers was measured to assess the correlation between MA and TEER. In the second study, duodenal MA of 21 patients with FD fulfilling the Rome III criteria was compared with that of 23 healthy subjects.

RESULTS: The mean MA and TEER values were 367.5±134.7 and 24.5±3.7 Ω cm

CONCLUSIONS: We demonstrated the presence of increased duodenal mucosal permeability in patients with FD by MA measurement using a simple catheterization method during upper endoscopy.

References

  1. Aliment Pharmacol Ther. 2008 Dec 1;28(11-12):1317-25 - PubMed
  2. J Gastroenterol Hepatol. 2010 Jun;25(6):1151-6 - PubMed
  3. Hepatogastroenterology. 2012 Jan-Feb;59(113):62-6 - PubMed
  4. Am J Gastroenterol. 2005 Jul;100(7):1477-88 - PubMed
  5. Neurogastroenterol Motil. 2008 Feb;20(2):125-33 - PubMed
  6. Gastroenterology. 2009 Jul;137(1):94-100 - PubMed
  7. Gastroenterology. 2002 Jun;122(7):1738-47 - PubMed
  8. Am J Gastroenterol. 2012 May;107(5):736-46 - PubMed
  9. Aliment Pharmacol Ther. 1997 Apr;11(2):395-402 - PubMed
  10. Dig Liver Dis. 2012 Mar;44(3):211-7 - PubMed
  11. Gastroenterology. 1999 Mar;116(3):515-20 - PubMed
  12. Am J Gastroenterol. 2012 Jan;107(1):75-81 - PubMed
  13. Gastroenterology. 1998 Dec;115(6):1346-52 - PubMed
  14. Clin Gastroenterol Hepatol. 2007 Oct;5(10):1175-83 - PubMed
  15. Aliment Pharmacol Ther. 2010 Jun;31(11):1229-36 - PubMed
  16. Am J Gastroenterol. 2010 Aug;105(8):1835-42 - PubMed
  17. Am J Gastroenterol. 2015 Aug;110(8):1205-15 - PubMed
  18. Clin Otolaryngol. 2015 Apr;40(2):106-14 - PubMed
  19. Gut. 2013 Aug;62(8):1160-8 - PubMed
  20. Aliment Pharmacol Ther. 2013 Oct;38(7):729-40 - PubMed
  21. Dig Dis Sci. 1991 Sep;36(9):1249-54 - PubMed
  22. ORL J Otorhinolaryngol Relat Spec. 2016;78(1):16-25 - PubMed
  23. Aliment Pharmacol Ther. 2012 Jan;35(1):175-82 - PubMed
  24. Gut. 2010 Jun;59(6):775-84 - PubMed
  25. Aliment Pharmacol Ther. 2002 Dec;16(12):2081-8 - PubMed
  26. Gut. 2014 May;63(5):744-52 - PubMed
  27. Gastroenterology. 2016 May;150(6):1380-92 - PubMed
  28. Dig Dis Sci. 1988 Feb;33(2):129-34 - PubMed
  29. Gut. 2014 Aug;63(8):1293-9 - PubMed
  30. Gut. 2014 Feb;63(2):262-71 - PubMed
  31. Neurogastroenterol Motil. 2009 Aug;21(8):832-e56 - PubMed
  32. Aliment Pharmacol Ther. 2009 Apr 1;29(7):765-73 - PubMed

Publication Types